State Of Wyoming Insmed Inc Transaction History

State Of Wyoming

$676 Million
Q3 2024

A detailed history of State Of Wyoming transactions in Insmed Inc stock. As of the latest transaction made, State Of Wyoming holds 1,557 shares of INSM stock, worth $114,984. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,557

Previous 1,916 18.74%

Holding current value

$114,984

Previous $128,000 11.72%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $22,258 - $28,364	-359 Reduced 18.74%	1,557 $113,000
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $4,620 - $14,639	210 Added 12.31%	1,916 $128,000
Q1 2024 May 13, 2024	SELL	$25.72 - $29.94 $2,854 - $3,323	-111 Reduced 6.11%	1,706 $46,000
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $5,339 - $7,236	228 Added 14.35%	1,817 $56,000
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $10,366 - $14,057	522 Added 48.92%	1,589 $40,000
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $4,619 - $5,929	281 Added 35.75%	1,067 $22,000
Q1 2023 May 12, 2023	SELL	$16.26 - $21.73 $12,422 - $16,601	-764 Reduced 49.29%	786 $13,000
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $26,319 - $35,882	1,550 New	1,550 $30,000
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $293,126 - $441,492	-17,172 Reduced 98.95%	183 $4,000
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $12,456 - $17,159	610 Added 3.64%	17,355 $408,000
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $31,534 - $40,742	1,218 Added 7.84%	16,745 $456,000
Q3 2021 Feb 11, 2022	SELL	$22.46 - $29.47 $6,625 - $8,693	-295 Reduced 1.86%	15,527 $427,000
Q2 2021 Feb 11, 2022	BUY	$24.17 - $36.01 $380,363 - $566,689	15,737 Added 18514.12%	15,822 $450,000
Q1 2021 Feb 08, 2022	BUY	$32.28 - $44.3 $2,743 - $3,765	85 New	85 $3,000

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account